TY - JOUR
T1 - Clinical significance of tubular and podocyte biomarkers in acute kidney injury
AU - Matsui, Katsuomi
AU - Kamijo-Ikemori, Atsuko
AU - Hara, Masanori
AU - Sugaya, Takeshi
AU - Kodama, Takamitsu
AU - Fujitani, Sigeki
AU - Taira, Yasuhiko
AU - Yasuda, Takashi
AU - Kimura, Kenjiro
N1 - Funding Information:
We thank Ms. Seiko Hoshino and Aya Sakamaki for assistance with the collection of urine and serum samples and for measuring urinary parameters. We would also like to thank Dr. Tokuichirou Nagata for obtaining informed consent from the patients. This study was approved by the ethics committee of St. marianna University School of Medicine Hospital, and was in adherence with the Declaration of Helsinki. No financial support was received for this study.
PY - 2011/4
Y1 - 2011/4
N2 - Background: Acute kidney injury (AKI) is a common complication in critically ill patients. Urinary excretion of liver-type fatty acid-binding protein (L-FABP), which is expressed in the proximal tubules, reflects the presence of tubular injury. Urinary excretion of podocalyxin (PCX), a glycoprotein prominently expressed on podocytes, is associated with podocyte injury. Our aims were to evaluate the utility of urinary L-FABP for the early detection of AKI and to examine whether podocyte injury is present in AKI patients using the biomarker of urinary PCX. Methods: Patients admitted to the intensive care unit (ICU) were divided into the AKI group (n = 14) and non-AKI group (n = 11), according to the occurrence of AKI during hospitalization in the ICU. Changes in various biomarkers were evaluated. Results: In the AKI group, elevation of urinary L-FABP level [maximum value of L-FABP, 199.0 (92.5-433.6) μg/g creatinine, median (25-75% interquartile range)], which reflects tubular injury (area under the curve 0.95, cut-off value 44.1 μg/g Cr), occurred between -30 and 0 h before the occurrence of AKI (i.e., the time at which serum creatinine peaked), and elevation of urinary PCX level [maximum value of PCX, 389.5 (267.0-501.0) μg/g creatinine; upper limit of reference value, 160 μg/g creatinine] occurred during the time of recovery from AKI when serum creatinine levels were decreasing between 34.0 and 72.0 h after the occurrence of AKI. Furthermore, a parameter with the primary large AUC for predicting the onset of AKI was urinary L-FABP. Conclusions: Our study suggests that L-FABP is a useful biomarker for early detection of AKI and that podocyte injury was induced during the recovery phase of AKI.
AB - Background: Acute kidney injury (AKI) is a common complication in critically ill patients. Urinary excretion of liver-type fatty acid-binding protein (L-FABP), which is expressed in the proximal tubules, reflects the presence of tubular injury. Urinary excretion of podocalyxin (PCX), a glycoprotein prominently expressed on podocytes, is associated with podocyte injury. Our aims were to evaluate the utility of urinary L-FABP for the early detection of AKI and to examine whether podocyte injury is present in AKI patients using the biomarker of urinary PCX. Methods: Patients admitted to the intensive care unit (ICU) were divided into the AKI group (n = 14) and non-AKI group (n = 11), according to the occurrence of AKI during hospitalization in the ICU. Changes in various biomarkers were evaluated. Results: In the AKI group, elevation of urinary L-FABP level [maximum value of L-FABP, 199.0 (92.5-433.6) μg/g creatinine, median (25-75% interquartile range)], which reflects tubular injury (area under the curve 0.95, cut-off value 44.1 μg/g Cr), occurred between -30 and 0 h before the occurrence of AKI (i.e., the time at which serum creatinine peaked), and elevation of urinary PCX level [maximum value of PCX, 389.5 (267.0-501.0) μg/g creatinine; upper limit of reference value, 160 μg/g creatinine] occurred during the time of recovery from AKI when serum creatinine levels were decreasing between 34.0 and 72.0 h after the occurrence of AKI. Furthermore, a parameter with the primary large AUC for predicting the onset of AKI was urinary L-FABP. Conclusions: Our study suggests that L-FABP is a useful biomarker for early detection of AKI and that podocyte injury was induced during the recovery phase of AKI.
KW - Acute kidney injury (AKI)
KW - Liver-type fatty acid-binding protein (L-FABP)
KW - Podocalyxin (PCX)
KW - Podocyte injury
UR - http://www.scopus.com/inward/record.url?scp=79959270411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959270411&partnerID=8YFLogxK
U2 - 10.1007/s10157-010-0384-y
DO - 10.1007/s10157-010-0384-y
M3 - Article
C2 - 21153750
AN - SCOPUS:79959270411
SN - 1342-1751
VL - 15
SP - 220
EP - 225
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
IS - 2
ER -